Production (Stage)
Ekso Bionics Holdings, Inc.
EKSO
$0.2798
$0.00120.43%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 15.29% | -64.72% | 14.24% | 29.54% | -6.69% |
| Total Depreciation and Amortization | -5.03% | -2.21% | 2.52% | -2.22% | -6.02% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -112.55% | 1,218.06% | -133.80% | -16.31% | 79.23% |
| Change in Net Operating Assets | 2,778.57% | 94.02% | 56.55% | -13.13% | -204.16% |
| Cash from Operations | -37.12% | 37.07% | 14.72% | 22.97% | -118.81% |
| Capital Expenditure | 52.38% | -162.50% | -- | 100.00% | 81.40% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 52.38% | -162.50% | -- | 100.00% | 81.40% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -0.32% | 0.32% | -0.32% | 0.32% | 0.00% |
| Issuance of Common Stock | -- | -- | 10,546.81% | -98.82% | 500.61% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,223.89% | -106.69% | 1,870.19% | -107.25% | 950.86% |
| Foreign Exchange rate Adjustments | 122.58% | -3,200.00% | -95.24% | 195.45% | -10.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 186.77% | -174.74% | 182.60% | -1,909.94% | 112.39% |